ArticleAntimicrobial agents and chemotherapy2019

A Novel VIM-Type Metallo-β-Lactamase Variant, VIM-60, with Increased Hydrolyzing Activity against Fourth-Generation Cephalosporins in Pseudomonas aeruginosa Clinical Isolates in Japan.

Tomomi Hishinuma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.